India · Delayed Price · Currency is INR NSE:HCG Statistics
Total Valuation
NSE:HCG has a market cap or net worth of INR 95.65 billion. The enterprise value is 111.23 billion.
| Market Cap | 95.65B |
| Enterprise Value | 111.23B |
Important Dates
The last earnings date was Friday, August 1, 2025.
| Earnings Date | Aug 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:HCG has 141.00 million shares outstanding. The number of shares has increased by 0.72% in one year.
| Current Share Class | 141.00M |
| Shares Outstanding | 141.00M |
| Shares Change (YoY) | +0.72% |
| Shares Change (QoQ) | -1.29% |
| Owned by Insiders (%) | 11.58% |
| Owned by Institutions (%) | 16.07% |
| Float | 39.21M |
Valuation Ratios
The trailing PE ratio is 258.41 and the forward PE ratio is 98.56.
| PE Ratio | 258.41 |
| Forward PE | 98.56 |
| PS Ratio | 4.14 |
| PB Ratio | 9.66 |
| P/TBV Ratio | 21.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 299.96 |
| EV / Sales | 4.81 |
| EV / EBITDA | 26.50 |
| EV / EBIT | 60.65 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.86 |
| Debt / EBITDA | 4.39 |
| Debt / FCF | n/a |
| Interest Coverage | 1.09 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 4.58% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 3.43M |
| Profits Per Employee | 55,048 |
| Employee Count | 6,736 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:HCG has paid 87.10 million in taxes.
| Income Tax | 87.10M |
| Effective Tax Rate | 17.46% |
Stock Price Statistics
The stock price has increased by +62.57% in the last 52 weeks. The beta is -0.12, so NSE:HCG's price volatility has been lower than the market average.
| Beta (5Y) | -0.12 |
| 52-Week Price Change | +62.57% |
| 50-Day Moving Average | 625.24 |
| 200-Day Moving Average | 551.27 |
| Relative Strength Index (RSI) | 57.04 |
| Average Volume (20 Days) | 307,488 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:HCG had revenue of INR 23.10 billion and earned 370.80 million in profits. Earnings per share was 2.63.
| Revenue | 23.10B |
| Gross Profit | 8.32B |
| Operating Income | 1.82B |
| Pretax Income | 498.90M |
| Net Income | 370.80M |
| EBITDA | 4.18B |
| EBIT | 1.82B |
| Earnings Per Share (EPS) | 2.63 |
Balance Sheet
The company has 3.48 billion in cash and 18.37 billion in debt, giving a net cash position of -14.90 billion or -105.64 per share.
| Cash & Cash Equivalents | 3.48B |
| Total Debt | 18.37B |
| Net Cash | -14.90B |
| Net Cash Per Share | -105.64 |
| Equity (Book Value) | 9.90B |
| Book Value Per Share | 66.43 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 36.03%, with operating and profit margins of 7.87% and 1.60%.
| Gross Margin | 36.03% |
| Operating Margin | 7.87% |
| Pretax Margin | 2.16% |
| Profit Margin | 1.60% |
| EBITDA Margin | 18.10% |
| EBIT Margin | 7.87% |
| FCF Margin | n/a |
Dividends & Yields
NSE:HCG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.72% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.39% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |